Literature DB >> 16272517

New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Antti J Hakanen1, Marianne Lindgren, Pentti Huovinen, Jari Jalava, Anja Siitonen, Pirkko Kotilainen.   

Abstract

We describe the emergence of a new quinolone resistance pattern in Salmonella enterica isolates from Southeast Asia. These isolates are susceptible to nalidixic acid but exhibit reduced susceptibility to ciprofloxacin. The increase of such strains may threaten the value of the nalidixic acid disk test to screen for reduced fluoroquinolone susceptibility in salmonellas.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16272517      PMCID： PMC1287832          DOI： 10.1128/JCM.43.11.5775-5778.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.

Authors:  Laura J V Piddock; Yu Fang Jin; Mark A Webber; Martin J Everett
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.

Authors:  N Moniot-Ville; J Guibert; N Moreau; J F Acar; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin.

Authors:  C Pers; P Søgaard; L Pallesen
Journal:  Scand J Infect Dis       Date:  1996

4.  An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

Authors:  K Mølbak; D L Baggesen; F M Aarestrup; J M Ebbesen; J Engberg; K Frydendahl; P Gerner-Smidt; A M Petersen; H C Wegener
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

5.  Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs.

Authors:  J C Brown; C J Thomson; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

Review 6.  Mechanisms of resistance to quinolones.

Authors:  George A Jacoby
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

7.  Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients.

Authors:  L J Piddock; D J Griggs; M C Hall; Y F Jin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium.

Authors:  Morten Helms; Pernille Vastrup; Peter Gerner-Smidt; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

9.  Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.

Authors:  D J Griggs; K Gensberg; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance.

Authors:  F Reyna; M Huesca; V González; L Y Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
View more
  11 in total

1.  Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.

Authors:  Anna Maria Dionisi; Claudia Lucarelli; Slawomir Owczarek; Ida Luzzi; Laura Villa
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

2.  Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.

Authors:  Christopher M Parry; Chau Tran Thuy; Sabina Dongol; Abhilasha Karkey; Ha Vinh; Nguyen Tran Chinh; Pham Thanh Duy; Tran Vu Thieu Nga; James I Campbell; Nguyen Van Minh Hoang; Amit Arjyal; Zulfiqar A Bhutta; Sujit K Bhattacharya; Magdarina D Agtini; Baiqing Dong; Do Gia Canh; Aliya Naheed; John Wain; Tran Tinh Hien; Buddha Basnyat; Leon Ochiai; John Clemens; Jeremy J Farrar; Christiane Dolecek; Stephen Baker
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

3.  In vitro activity of azithromycin against nontyphoidal Salmonella enterica.

Authors:  Marianne Gunell; Pirkko Kotilainen; Jari Jalava; Pentti Huovinen; Anja Siitonen; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

4.  Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.

Authors:  Marianne Gunell; Mark A Webber; Pirkko Kotilainen; Andrew J Lilly; Jonathan M Caddick; Jari Jalava; Pentti Huovinen; Anja Siitonen; Antti J Hakanen; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

5.  Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain.

Authors:  M E Cano; J M Rodríguez-Martínez; J Agüero; A Pascual; J Calvo; J M García-Lobo; C Velasco; M V Francia; L Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

6.  Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections.

Authors:  Manar Al-Mashhadani; Robert Hewson; Roberto Vivancos; Alex Keenan; Nick J Beeching; John Wain; Christopher M Parry
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

7.  Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.

Authors:  Marianne M Lindgren; Pirkko Kotilainen; Pentti Huovinen; Saija Hurme; Susanna Lukinmaa; Mark A Webber; Laura J V Piddock; Anja Siitonen; Antti J Hakanen
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

8.  Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases.

Authors:  Octavie Lunguya; Veerle Lejon; Marie-France Phoba; Sophie Bertrand; Raymond Vanhoof; Youri Glupczynski; Jan Verhaegen; Jean-Jacques Muyembe-Tamfum; Jan Jacobs
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14

9.  Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins.

Authors:  Jean M Whichard; Kathryn Gay; Jennifer E Stevenson; Kevin J Joyce; Kara L Cooper; Michael Omondi; Felicita Medalla; George A Jacoby; Timothy J Barrett
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

10.  Renaissance of Conventional First-Line Antibiotics in Salmonella enterica Clinical Isolates: Assessment of MICs for Therapeutic Antimicrobials in Enteric Fever Cases from Nepal.

Authors:  Puspa Raj Khanal; Deepa Satyal; Anjeela Bhetwal; Anjila Maharjan; Shreena Shakya; Snehika Tandukar; Narayan Prasad Parajuli
Journal:  Biomed Res Int       Date:  2017-09-05       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.